197 related articles for article (PubMed ID: 12429803)
1. Over-expression of p45(SKP2) in Kaposi's sarcoma correlates with higher tumor stage and extracutaneous involvement but is not directly related to p27(KIP1) down-regulation.
Penin RM; Fernandez-Figueras MT; Puig L; Rex J; Ferrandiz C; Ariza A
Mod Pathol; 2002 Nov; 15(11):1227-35. PubMed ID: 12429803
[TBL] [Abstract][Full Text] [Related]
2. Decreased immunoreactivity for cell-cycle regulator p27(Kip1) in Kaposi's sarcoma correlates with higher stage and extracutaneous involvement.
Fernández-Figueras MT; Puig L; Penín RM; Mate JL; Bigatà X; Ariza A
J Pathol; 2000 Aug; 191(4):387-93. PubMed ID: 10918213
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of F-Box protein p45(SKP2) expression and stabilization of cyclin-dependent kinase inhibitor p27(KIP1) in vitamin D analog-treated cancer cells.
Lin R; Wang TT; Miller WH; White JH
Endocrinology; 2003 Mar; 144(3):749-53. PubMed ID: 12586749
[TBL] [Abstract][Full Text] [Related]
4. Cytoplasmic ubiquitin ligase KPC regulates proteolysis of p27(Kip1) at G1 phase.
Kamura T; Hara T; Matsumoto M; Ishida N; Okumura F; Hatakeyama S; Yoshida M; Nakayama K; Nakayama KI
Nat Cell Biol; 2004 Dec; 6(12):1229-35. PubMed ID: 15531880
[TBL] [Abstract][Full Text] [Related]
5. Degradation of p27(Kip1) at the G(0)-G(1) transition mediated by a Skp2-independent ubiquitination pathway.
Hara T; Kamura T; Nakayama K; Oshikawa K; Hatakeyama S; Nakayama K
J Biol Chem; 2001 Dec; 276(52):48937-43. PubMed ID: 11682478
[TBL] [Abstract][Full Text] [Related]
6. Troglitazone induces p27Kip1-associated cell-cycle arrest through down-regulating Skp2 in human hepatoma cells.
Koga H; Harada M; Ohtsubo M; Shishido S; Kumemura H; Hanada S; Taniguchi E; Yamashita K; Kumashiro R; Ueno T; Sata M
Hepatology; 2003 May; 37(5):1086-96. PubMed ID: 12717389
[TBL] [Abstract][Full Text] [Related]
7. Expression of Skp2, a p27(Kip1) ubiquitin ligase, in malignant lymphoma: correlation with p27(Kip1) and proliferation index.
Lim MS; Adamson A; Lin Z; Perez-Ordonez B; Jordan RC; Tripp S; Perkins SL; Elenitoba-Johnson KS
Blood; 2002 Oct; 100(8):2950-6. PubMed ID: 12351407
[TBL] [Abstract][Full Text] [Related]
8. Early mitotic inhibitor-1, an anaphase-promoting complex/cyclosome inhibitor, can control tumor cell proliferation in hepatocellular carcinoma: correlation with Skp2 stability and degradation of p27(Kip1).
Zhao Y; Tang Q; Ni R; Huang X; Wang Y; Lu C; Shen A; Wang Y; Li C; Yuan Q; Chen H; Cheng C; He S
Hum Pathol; 2013 Mar; 44(3):365-73. PubMed ID: 22995332
[TBL] [Abstract][Full Text] [Related]
9. Modification of cullin-1 by ubiquitin-like protein Nedd8 enhances the activity of SCF(skp2) toward p27(kip1).
Morimoto M; Nishida T; Honda R; Yasuda H
Biochem Biophys Res Commun; 2000 Apr; 270(3):1093-6. PubMed ID: 10772955
[TBL] [Abstract][Full Text] [Related]
10. p27 Kip1 protein expression in Hashimoto's thyroiditis.
Troncone G; Iaccarino A; Caleo A; Bifano D; Pettinato G; Palombini L
J Clin Pathol; 2003 Aug; 56(8):587-91. PubMed ID: 12890807
[TBL] [Abstract][Full Text] [Related]
11. Damage-specific DNA binding protein 1 (DDB1) is involved in ubiquitin-mediated proteolysis of p27Kip1 in response to UV irradiation.
Iovine B; Iannella ML; Bevilacqua MA
Biochimie; 2011 May; 93(5):867-75. PubMed ID: 21237244
[TBL] [Abstract][Full Text] [Related]
12. [Correlation of Skp2 and P27kip1 protein expression and clinicopathological features of prostate cancer].
Zheng XY; Ding W; Xie LP; Chen ZD
Ai Zheng; 2004 Feb; 23(2):215-8. PubMed ID: 14960249
[TBL] [Abstract][Full Text] [Related]
13. High expression of S-phase kinase-interacting protein 2, human F-box protein, correlates with poor prognosis in oral squamous cell carcinomas.
Kudo Y; Kitajima S; Sato S; Miyauchi M; Ogawa I; Takata T
Cancer Res; 2001 Oct; 61(19):7044-7. PubMed ID: 11585732
[TBL] [Abstract][Full Text] [Related]
14. Association of human CUL-1 and ubiquitin-conjugating enzyme CDC34 with the F-box protein p45(SKP2): evidence for evolutionary conservation in the subunit composition of the CDC34-SCF pathway.
Lisztwan J; Marti A; Sutterlüty H; Gstaiger M; Wirbelauer C; Krek W
EMBO J; 1998 Jan; 17(2):368-83. PubMed ID: 9430629
[TBL] [Abstract][Full Text] [Related]
15. Skp2 is oncogenic and overexpressed in human cancers.
Gstaiger M; Jordan R; Lim M; Catzavelos C; Mestan J; Slingerland J; Krek W
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5043-8. PubMed ID: 11309491
[TBL] [Abstract][Full Text] [Related]
16. Protein-protein interactions involved in the recognition of p27 by E3 ubiquitin ligase.
Xu K; Belunis C; Chu W; Weber D; Podlaski F; Huang KS; Reed SI; Vassilev LT
Biochem J; 2003 May; 371(Pt 3):957-64. PubMed ID: 12529174
[TBL] [Abstract][Full Text] [Related]
17. Inverse relation between levels of p27(Kip1) and of its ubiquitin ligase subunit Skp2 in colorectal carcinomas.
Hershko D; Bornstein G; Ben-Izhak O; Carrano A; Pagano M; Krausz MM; Hershko A
Cancer; 2001 May; 91(9):1745-51. PubMed ID: 11335900
[TBL] [Abstract][Full Text] [Related]
18. Expression of p27 and its ubiquitin ligase subunit Skp2 in upper urinary tract transitional cell carcinoma.
Langner C; von Wasielewski R; Ratschek M; Rehak P; Zigeuner R
Urology; 2004 Sep; 64(3):611-6. PubMed ID: 15351619
[TBL] [Abstract][Full Text] [Related]
19. Targeted disruption of Skp2 results in accumulation of cyclin E and p27(Kip1), polyploidy and centrosome overduplication.
Nakayama K; Nagahama H; Minamishima YA; Matsumoto M; Nakamichi I; Kitagawa K; Shirane M; Tsunematsu R; Tsukiyama T; Ishida N; Kitagawa M; Nakayama K; Hatakeyama S
EMBO J; 2000 May; 19(9):2069-81. PubMed ID: 10790373
[TBL] [Abstract][Full Text] [Related]
20. Expression of the F-box protein SKP2 induces hyperplasia, dysplasia, and low-grade carcinoma in the mouse prostate.
Shim EH; Johnson L; Noh HL; Kim YJ; Sun H; Zeiss C; Zhang H
Cancer Res; 2003 Apr; 63(7):1583-8. PubMed ID: 12670908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]